AbbVie results beat expectations despite low-cost competition to blockbuster Humira By: MarketWatch October 27, 2023 at 07:42 AM EDT Drugmaker raises its full-year earnings outlook, boosts 2024 dividend 4.7% Read More >> Related Stocks: AbbVie
